Jaw, EdentulousNCT04545840
Prospective Neodent® Zirconia System Study
An observational study of Jaw, Edentulous and Jaw, Edentulous, Partially, run by Neodent at 1 site in Brazil.
Trial summary
The Neodent® Zirconia Implant is designed for the treatment of oral endosteal implantation for the functional and aesthetic rehabilitation, allowing for treatment of patients with different bone qualities. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Jaw, Edentulous, Jaw, Edentulous, Partially
- What is being tested?
- Dental Implants
- Type of treatment
- Medical device
- How many people
- 36 participants
- Where
- 1 siteBrazil
- Study dates
- 10 Sep 2020to 30 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients 18 years of age or older who are in need of and who qualify for single dental implants placement in the posterior maxilla region with Neodent® Zirconia Implants. Patients that give written informed consent to participate in this clinical study.
Who may be able to join
- 18 years of age or older;
- Maxillary posterior teeth missing, with adjacent natural teeth;
- Patient who are in need of oral rehabilitation with dental implants and single prostheses and qualify for placement of Zirconia Implants.
Who cannot join
- Subjects under 18 years of age, pregnant or breastfeeding women. And patients that present the device contraindications according to the IFU (instructions for use):
- Signs of allergy or hypersensitivity to the chemical ingredients of the material: Zirconia (Y-ZTP), Zirconium dioxide (ZrO2), Yttrium oxide (Y2O3), Hafnium dioxide (HfO2), Aluminum oxide (Al2O3);
- Acute inflammatory or infectious processes;
- Unsuitable bone volume or quality;
- Serious medical problems (e.g. bone metabolism disorders, blood clotting disorders, unsuitable healing capacity);
- Incomplete jawbone growth;
Show all 17Show fewer
- Patient uncooperative and not motivated;
- Hypochondria;
- Alcoholism;
- Psychosis;
- Prolonged functional disorders which resist any treatment with medications;
- Xerostomia;
- Weakened immunological system;
- Diseases which require regular use of steroids;
- Uncontrolled endocrine diseases;
- Insufficient oral hygiene;
- Pregnancy;
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Instituto Latino Americano de Pesquisa e Ensino Odontológico (ILAPEO)
Curitiba, Paraná, 80710-150
About this study
Official title: Prospective Study of Neodent® Implantable Devices of Zirconia System
The Neodent® Zirconia Implant is designed for the treatment of oral endosteal implantation for the functional and aesthetic rehabilitation, allowing for treatment of patients with different bone qualities.
The objective of the study is to assess the success and survival rates of implantable devices of the Zirconia System, in order to confirm the long-term safety and clinical performance of implants and abutments of the Zirconia System in daily dental practice setting.
Devices will be used according to standard routine in daily practice, according to manufacturer indications in the IFU. Patients will be followed for 36 months after implant placement.
Read the detailed description
The study protocol was reviewed and approved by an Ethics Committee (CE) in Brazil. The sample will be prospectively and consecutively selected and will consist of patients who are 18 years of age or older, who are in need of and who qualify for single dental implants placement in the posterior maxilla region with Neodent® Zirconia. Informed consent in writing will be obtained from each patient participating in the study prior to any study related procedure.
As this study will be analyzed descriptively, sample size calculation was not performed. To generate reliable results, a total number of 30 implants was assumed to be sufficient. Estimating a rate of 1 implant per patient and a drop-out rate of 15%, a sample size of 36 patients resulting in an estimated number of 36 implants is thought to be sufficient to allow for a descriptive analysis of clinical outcome data up to 36 months after implant placement.
Treatment provided to the subjects will be the responsibility of an appropriately qualified dental practitioner to provide the relevant patient care under clinical study conditions. Zirconia Implants will be placed under local anesthesia and with adequate bone bed preparation in posterior maxilla region. More than one implant can be placed in the same patient, as long as the subject presents natural teeth adjacent to the implant site.
Immediately after implant placement, the final placement torque will be registered. The immediate loading will be applied within 48 hours with the insertion of a provisional prosthesis made from intraoral scanning or scanning of dental casts obtained by conventional impression. The insertion torque shall reach at least 35 N.cm and the subject must have physiologic occlusion to immediate loading. If the patient does not reach the minimum torque (35 N.cm), the patient will be followed until the study end but will not be considered to final statistic or, a different implant line would be placed and the study termination form will be filled. The principal investigator will choose how to procedure in this situation. The selection of the prosthetic component shall be conducted according to the need of each subject and to the manufacturer's instructions (IFU). The final prosthesis will be placed 2 months after implant loading.
Data concerning the studied variables will be collected following the procedures and assessments plan by fulfilling the Case Report Form (CRF), in the following stages: screening (First visit); TP - Implant(s) placement and impression/scanning for temporary prosthesis preparation; T0 - Implant(s) loading (up to 48h after placement); TF - Final prosthesis placement (2 months ± 1 week after loading); T6, T12, T24, T36 - 6, 12, 24 e 36 ± 1 month, respectively, after loading.
Standardized digital periapical radiographs will be obtained in a usual daily practice frequency, as determined by the investigator: at pre-operative, to assess the ridge height and width of the supporting bone and locate major anatomical features; in post-surgery (TP) and in T0, TF, T6, T12, T24 and T36 to verify prosthesis adaptation and osseointegration. Computed tomography scans will be obtained from the region of interest prior to surgery, for the selection of the implant to be inserted.
- Conditions
- Jaw, Edentulous, Jaw, Edentulous, Partially
- Being tested
- Dental Implants
- Keywords
- Dental Implants, Mouth Rehabilitation
- Medical subject headings
- Jaw, Edentulous, Jaw, Edentulous, Partially
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dental ImplantsDevice
Dental Implants will be used according to standard routine in daily practice, according to all indications as specified by the manufacturer in the IFU (informations for use).
| Study group | Role | What they receive |
|---|---|---|
| Study group | Zirconia Implants will be placed. More than one implant can be placed in the same patient, as long as the subject presents natural teeth adjacent to the implant site. Receives: Device: Dental Implants |
What is being measured
The primary outcome is the main question the study is designed to answer.
Implant survival rate
Implant survival will be defined as no loss of the implant.
Measured: 36 months after implant placement
Implant success rate
Evaluation of implant success will be assessed based on the criteria proposed by Buser et al. (1990).
Measured: 36 months after implant placement
Secondary outcomes (7)
Implant survival rate
Implant survival will be defined as no loss of the implant.
Measured: 6 months after implant placement
Implant success rate
Evaluation of implant success will be assessed based on the criteria proposed by Buser et al. (1990).
Measured: 6 months after implant placement
Prosthetic survival rate
Prosthetic survival will be assessed as the final prosthesis remaining in situ, irrespective of its condition.
Measured: 36 months after implant placement
Prosthetic success rate
Success will be defined as the prosthesis that remained unchanged and did not require any intervention, except routine occlusal adjustments, during the entire observational period
Measured: 36 months after implant placement
Patient satisfaction: questionnaire
OHIP-14 questionnaire will be used to assess Oral Health Related Quality of Life (OHRQoL), as a measure of patient satisfaction with treatment. Patients will be asked how frequently they have been experiencing the problems assessed by the questionnaire. Small values mean a better quality of life.
Measured: At screening visit, after the temporary prosthesis period and 6, 12, 24 and 36 months after implant placement
Clinician satisfaction: questionnaire
The assessment will be performed by means of a questionnaire using a visual analog scale (VAS) in the form of a 10 cm horizontal line, where 0 (left end) indicates minimum satisfaction and 10 (right end) indicates maximum satisfaction. The clinician will be instructed to mark the position considered to best represent their degree of general satisfaction with patient treatment. The score will be measured in centimeters from the left end of the line to the marked point.
Measured: At implant placement, implant loading and 6, 12, 24 and 36 months after implant placement
Rate of adverse events related to the implant, prosthesis, surgery and oral health
Determined by inquiring with the patient and clinical evaluation.
Measured: At implant placement, implant loading, final prosthesis placement and 6, 12, 24 and 36 months after implant placement
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Sep 2020
- Study start10 Sep 2020
- Primary completion30 Sep 2023
- Study completion30 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Jaw, EdentulousStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Neodent
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Larissa Trojan, PhD, Study chair, Neodent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04545840
- Sponsor's protocol ID
- CS.O.010
- Status last verified
- Nov 2023
- First submitted
- 4 Sep 2020
- Last updated
- 9 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective Study of Neodent® Implantable Devices of Zirconia System
- ClinicalTrials.gov ID
- NCT04545840
- Acronym / sponsor ID
- CS.O.010
- Conditions
- Jaw, Edentulous, Jaw, Edentulous, Partially
- Keywords
- Dental Implants, Mouth Rehabilitation
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- NeodentIndustry (pharma, biotech, devices)
- Study start
- 10 Sep 2020 (actual)
- Primary completion
- 30 Sep 2023 (actual)
- Study completion
- 30 Dec 2024 (estimated)
- First posted
- 11 Sep 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Neodent® Zirconia Implant is designed for the treatment of oral endosteal implantation for the functional and aesthetic rehabilitation, allowing for treatment of patients with different bone qualities.
The objective of the study is to assess the success and survival rates of implantable devices of the Zirconia System, in order to confirm the long-term safety and clinical performance of implants and abutments of the Zirconia System in daily dental practice setting.
Devices will be used according to standard routine in daily practice, according to manufacturer indications in the IFU. Patients will be followed for 36 months after implant placement.
Detailed description
The study protocol was reviewed and approved by an Ethics Committee (CE) in Brazil. The sample will be prospectively and consecutively selected and will consist of patients who are 18 years of age or older, who are in need of and who qualify for single dental implants placement in the posterior maxilla region with Neodent® Zirconia. Informed consent in writing will be obtained from each patient participating in the study prior to any study related procedure.
As this study will be analyzed descriptively, sample size calculation was not performed. To generate reliable results, a total number of 30 implants was assumed to be sufficient. Estimating a rate of 1 implant per patient and a drop-out rate of 15%, a sample size of 36 patients resulting in an estimated number of 36 implants is thought to be sufficient to allow for a descriptive analysis of clinical outcome data up to 36 months after implant placement.
Treatment provided to the subjects will be the responsibility of an appropriately qualified dental practitioner to provide the relevant patient care under clinical study conditions. Zirconia Implants will be placed under local anesthesia and with adequate bone bed preparation in posterior maxilla region. More than one implant can be placed in the same patient, as long as the subject presents natural teeth adjacent to the implant site.
Immediately after implant placement, the final placement torque will be registered. The immediate loading will be applied within 48 hours with the insertion of a provisional prosthesis made from intraoral scanning or scanning of dental casts obtained by conventional impression. The insertion torque shall reach at least 35 N.cm and the subject must have physiologic occlusion to immediate loading. If the patient does not reach the minimum torque (35 N.cm), the patient will be followed until the study end but will not be considered to final statistic or, a different implant line would be placed and the study termination form will be filled. The principal investigator will choose how to procedure in this situation. The selection of the prosthetic component shall be conducted according to the need of each subject and to the manufacturer's instructions (IFU). The final prosthesis will be placed 2 months after implant loading.
Data concerning the studied variables will be collected following the procedures and assessments plan by fulfilling the Case Report Form (CRF), in the following stages: screening (First visit); TP - Implant(s) placement and impression/scanning for temporary prosthesis preparation; T0 - Implant(s) loading (up to 48h after placement); TF - Final prosthesis placement (2 months ± 1 week after loading); T6, T12, T24, T36 - 6, 12, 24 e 36 ± 1 month, respectively, after loading.
Standardized digital periapical radiographs will be obtained in a usual daily practice frequency, as determined by the investigator: at pre-operative, to assess the ridge height and width of the supporting bone and locate major anatomical features; in post-surgery (TP) and in T0, TF, T6, T12, T24 and T36 to verify prosthesis adaptation and osseointegration. Computed tomography scans will be obtained from the region of interest prior to surgery, for the selection of the implant to be inserted.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Study group | – | Device: Dental ImplantsZirconia Implants will be placed. More than one implant can be placed in the same patient, as long as the subject presents natural teeth adjacent to the implant site. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients 18 years of age or older who are in need of and who qualify for single dental implants placement in the posterior maxilla region with Neodent® Zirconia Implants. Patients that give written informed consent to participate in this clinical study.
Key inclusion criteria (3 listed)
- 18 years of age or older;
- Maxillary posterior teeth missing, with adjacent natural teeth;
- Patient who are in need of oral rehabilitation with dental implants and single prostheses and qualify for placement of Zirconia Implants.
Key exclusion criteria (17 listed)
- Subjects under 18 years of age, pregnant or breastfeeding women. And patients that present the device contraindications according to the IFU (instructions for use):
- Signs of allergy or hypersensitivity to the chemical ingredients of the material: Zirconia (Y-ZTP), Zirconium dioxide (ZrO2), Yttrium oxide (Y2O3), Hafnium dioxide (HfO2), Aluminum oxide (Al2O3);
- Acute inflammatory or infectious processes;
- Unsuitable bone volume or quality;
- Serious medical problems (e.g. bone metabolism disorders, blood clotting disorders, unsuitable healing capacity);
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dental ImplantsDental Implants will be used according to standard routine in daily practice, according to all indications as specified by the manufacturer in the IFU (informations for use). | Device | Study group |
Primary outcome
Implant survival rate
Time frame: 36 months after implant placement
Implant survival will be defined as no loss of the implant.
Implant success rate
Time frame: 36 months after implant placement
Evaluation of implant success will be assessed based on the criteria proposed by Buser et al. (1990).
7 secondary outcomes
Implant survival rate
Time frame: 6 months after implant placement
Implant success rate
Time frame: 6 months after implant placement
Prosthetic survival rate
Time frame: 36 months after implant placement
Prosthetic success rate
Time frame: 36 months after implant placement
Patient satisfaction: questionnaire
Time frame: At screening visit, after the temporary prosthesis period and 6, 12, 24 and 36 months after implant placement
Clinician satisfaction: questionnaire
Time frame: At implant placement, implant loading and 6, 12, 24 and 36 months after implant placement
Rate of adverse events related to the implant, prosthesis, surgery and oral health
Time frame: At implant placement, implant loading, final prosthesis placement and 6, 12, 24 and 36 months after implant placement
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Nov 2023.
- Individual participant dataSharing planned: No
Related trials for Jaw, Edentulous
Active, not recruiting
Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations
Jaw, Edentulous, Partially
Recruiting
Clinical and Radiographic Evaluation of UV-Treated Dental Implants With or Without Melatonin in the Upper Posterior Jaw
Jaw, Edentulous, Partially, Bone Resorption
Active, not recruiting
A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration
Jaw, Edentulous, Partially
Recruiting
Clinical Outcomes of 3D Printed and Milled Complete Dentures
Edentulous Mouth, Edentulous Jaw
Active, not recruiting
Accuracy of Complete-arch Implant Scans Obtained Using T-Marker
Edentulous Jaw
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Larissa Trojan, PhD study chair
Neodent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Jaw, Edentulous and Jaw, Edentulous, Partially, run by Neodent at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Implant survival rate (time frame: 36 months after implant placement). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2023.